Results 301 to 310 of about 26,327 (353)

Cardiac resynchronization therapy for enabling guideline‐directed medical therapy optimization in heart failure

open access: yesEuropean Journal of Heart Failure, Volume 27, Issue 10, Page 1820-1833, October 2025.
Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the
Daniela Tomasoni   +17 more
wiley   +1 more source

The Role of Neprilysin and Insulin-Degrading Enzyme in the Etiology of Sporadic Alzheimer's Disease. [PDF]

open access: yesJ Neurosci
Morito T   +16 more
europepmc   +1 more source

Pharmacological management of heart failure. [PDF]

open access: yesJ Family Med Prim Care
Gupta H, Verma R.
europepmc   +1 more source

Impact of Angiotensin Receptor-Neprilysin Inhibitors on Patients With Acute Heart Failure Syndrome. [PDF]

open access: yesCureus
Aristizabal-Colorado D   +5 more
europepmc   +1 more source

Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. [PDF]

open access: yesEur Heart J
Peikert A   +17 more
europepmc   +1 more source

Copper Downregulates Neprilysin Activity Through Modulation of Neprilysin Degradation [PDF]

open access: possibleJournal of Alzheimer's Disease, 2010
Copper plays a central role in conserved processes such as respiration, and in highly specialized processes, such as protein modification. The metalloprotease neprilysin (NEP) degrades a variety of bioactive peptides and is involved in many physiological processes. However, very little is known about the regulation of NEP activity. In the current study,
Huan Yang   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy